Results 221 to 230 of about 87,487 (309)
Urinary Inflammatory and Oxidative Stress Biomarkers as Indicators for the Clinical Management of Benign Prostatic Hyperplasia. [PDF]
Jiang YH, Lee J, Kuo HC, Wu YH.
europepmc +1 more source
PSMA‐PET – Prostate Cancer Imaging in the Modern Era
ABSTRACT The management of prostate cancer relies on accurate staging. Prostate specific membrane antigen (PSMA) is a transmembrane glycoprotein highly expressed in prostate tissues, particularly prostate cancer. PSMA positron emission tomography (PSMA‐PET) is an emerging imaging modality that has recently established roles in prostate cancer imaging ...
Shravankrishna Ananthapadmanabhan+3 more
wiley +1 more source
Opioid prescribing patterns following surgical interventions for benign prostatic hyperplasia. [PDF]
Gressler LE+7 more
europepmc +1 more source
Prostate brachytherapy in patients with median lobe hyperplasia [PDF]
Kent E. Wallner+4 more
openalex +1 more source
Nearly all cases of cryptococcosis in koalas are caused by Cryptococcus gattii species complex. A rare case of meningitis due to Cryptococcus neoformans VNI/AFLP1 (abbreviated VNI) is described in a koala with nasal colonisation by both species complexes.
A Teh+6 more
wiley +1 more source
Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia. [PDF]
Zhu C+18 more
europepmc +1 more source
Correlation of Lower Urinary Tract Symptoms with Prostate Volume Parameters including Resistive Index and Presumed Circle Area Ratio in the Evaluation of Benign Prostatic Hyperplasia [PDF]
Myung-Soo Jeong, Jeong-Gu Lee
openalex +1 more source